Literature DB >> 26402225

Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7.

Ning Song, Hao Liu, Xiaoxin Ma, Shulan Zhang.   

Abstract

BACKGROUND/AIMS: Elucidation of the molecular mechanisms underlying ovarian cancer (OC) cell invasion and migration may provide important evidence for developing efficient therapy. Recently, Matrix metalloproteinase (MMP) has been shown to be regulated by vascular endothelial growth factor family members, especially placental growth factor (PLGF), as a potential mechanism underlying cancer invasion. Here, we studied the molecular relationship between PLGF and MMP7 in the OC.
METHODS: We examined the levels of PLGF and MMP7 in the resected OC specimens and compared to paired adjacent non-tumor ovarian tissue. We also examined the correlation between PLGF and MMP7. We modified PLGF levels in a human OC cell line, OVCAR3, and analyzed the effects on MMP7. Prediction of microRNA (miRNA) binding to 3'-UTR of MMP7 mRNA was performed by bioinformatics analyses and confirmed by a dual luciferase reporter assay using miR-543-modifed OC cells. The levels of miR-543 were examined in the OC specimens, and the correlation between miR-543 and PLGF or MMP7 was performed.
RESULTS: PLGF and MMP7 both significantly increased in the OC specimens, compared to paired adjacent non-tumor ovarian tissue. PLGF significantly increased MMP7 in the OC cells at protein level, but not at mRNA level. In OC cells, PLGF significantly decreased the levels of miR-543, which suppressed the translation of MMP7 mRNA via 3'-UTR binding. In OC specimen, miR-543 significantly decreased, compared to paired adjacent non-tumor ovarian tissue. An inverse correlation was detected between the levels of miR-543 and PLGF or MMP7 in the OC specimens.
CONCLUSION: MiR-543 inhibits translation of MMP7 through binding to the 3'-UTR of MMP7 mRNA in OC. PLGF suppresses miR-543, which activates MMP7-mediated cancer invasion.
© 2015 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26402225     DOI: 10.1159/000430235

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  21 in total

1.  Upregulation of microRNA-18b induces phosphatase and tensin homolog to accelerate the migration and invasion abilities of ovarian cancer.

Authors:  Xiaofang Han; Yan Zhang; Dong Wang; Xinyun Fu; Meiqing Li; Aiming Wang
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

Review 2.  Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

3.  The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition.

Authors:  Ling Zhao; Linjuan Huang; Jing Zhang; Jiaming Fan; Fang He; Xia Zhao; Hao Wang; Qing Liu; Deyao Shi; Na Ni; William Wagstaff; Mikhail Pakvasa; Kai Fu; Andrew B Tucker; Connie Chen; Russell R Reid; Rex C Haydon; Hue H Luu; Le Shen; Hongbo Qi; Tong-Chuan He
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Peroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression.

Authors:  Hua-Yu Zhu; Wen-Dong Bai; Hong-Tao Wang; Song-Tao Xie; Ke Tao; Lin-Lin Su; Jia-Qi Liu; Xue-Kang Yang; Jun Li; Yun-Chuan Wang; Ting He; Jun-Tao Han; Da-Hai Hu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

Review 5.  Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.

Authors:  Jamie N Frediani; Muller Fabbri
Journal:  Mol Cancer       Date:  2016-05-26       Impact factor: 27.401

6.  Hypoxia activates placental growth factor expression in lymphatic endothelial cells.

Authors:  Laura Tudisco; Augusto Orlandi; Valeria Tarallo; Sandro De Falco
Journal:  Oncotarget       Date:  2017-05-16

7.  Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.

Authors:  Manu Shivakumar; Younghee Lee; Lisa Bang; Tullika Garg; Kyung-Ah Sohn; Dokyoon Kim
Journal:  BMC Med Genomics       Date:  2017-05-24       Impact factor: 3.063

8.  MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK.

Authors:  Po Chen; Wentao Xu; Yi Luo; Yi Zhang; Yi He; Shuo Yang; Zhijun Yuan
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

9.  Molecular Characterisation of Uterine Endometrial Proteins during Early Stages of Pregnancy in Pigs by MALDI TOF/TOF.

Authors:  Dorota Pierzchała; Kamila Liput; Agnieszka Korwin-Kossakowska; Magdalena Ogłuszka; Ewa Poławska; Agata Nawrocka; Paweł Urbański; Aleksandra Ciepłoch; Edyta Juszczuk-Kubiak; Adam Lepczyński; Brygida Ślaska; Krzysztof Kowal; Marinus F W Te Pas; Magdalena Śmiech; Paweł Leszczyński; Hiroaki Taniguchi; Leyland Fraser; Przemysław Sobiech; Mateusz Sachajko; Magdalena Herudzinska; Chandra S Pareek; Mariusz Pierzchała
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

10.  Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.

Authors:  Claire Henry; Neville Hacker; Caroline Ford
Journal:  Oncotarget       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.